Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukemic Cell Antigens
- Molecular classification
- Protein, Glycoprotein, Transcription factor, Tyrosine phosphatase, Cell surface marker
01
Overview
Leukemic cell antigens are molecules, typically proteins or glycoproteins, expressed on the surface or within leukemic cells. These antigens can be unique to leukemic cells (tumor-specific) or shared with normal hematopoietic cells but overexpressed or aberrantly presented in leukemia. They serve as important biomarkers for diagnosis, classification, prognosis, and as targets for immunotherapy.
- Other names
- Leukemia-Associated Antigens (LAAs)Tumor-Specific Antigens (Leukemia)Common Acute Lymphoblastic Leukemia AntigenThymus-Leukemia AntigenCD45/Leukocyte Common Antigen
02
Mechanism of action
Varies depending on the specific antigen and therapeutic approach, including direct cytotoxicity, immune cell activation, and targeted drug delivery.
03
Biological functions
Cell signalingImmune recognitionRegulation of apoptosisRegulation of proliferationCell survivalDifferentiation marker
04
Disease associations
LeukemiaAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
05
Safety considerations
Off-target effects of immunotherapiesCytokine release syndrome (CRS) in CAR-T therapyTumor lysis syndromeImmune-related adverse events
06
Interacting drugs
Monoclonal antibodies
3 more in the full profile.
07
Biomarkers
Expression levels of specific antigensWT1 expressionPRAME expressionCD45 expressionLineage-specific markers (e.g., CD19, CD33, CD3)
Beyond the preview
Go deeper on Leukemic Cell Antigens.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Leukemic Cell Antigens.